These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
915 related articles for article (PubMed ID: 18603297)
1. Detection of BCR-ABL gene mutations in Philadelphia chromosome positive leukemia patients resistant to STI-571 cancer therapy. Chien JH; Tang JL; Chen RL; Li CC; Lee CP Leuk Res; 2008 Nov; 32(11):1724-34. PubMed ID: 18603297 [TBL] [Abstract][Full Text] [Related]
2. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation. Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172 [TBL] [Abstract][Full Text] [Related]
3. Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on Chronic Myeloid Leukemia. Soverini S; Colarossi S; Gnani A; Rosti G; Castagnetti F; Poerio A; Iacobucci I; Amabile M; Abruzzese E; Orlandi E; Radaelli F; Ciccone F; Tiribelli M; di Lorenzo R; Caracciolo C; Izzo B; Pane F; Saglio G; Baccarani M; Martinelli G; Clin Cancer Res; 2006 Dec; 12(24):7374-9. PubMed ID: 17189410 [TBL] [Abstract][Full Text] [Related]
4. Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy. Hochhaus A; Kreil S; Corbin AS; La Rosée P; Müller MC; Lahaye T; Hanfstein B; Schoch C; Cross NC; Berger U; Gschaidmeier H; Druker BJ; Hehlmann R Leukemia; 2002 Nov; 16(11):2190-6. PubMed ID: 12399961 [TBL] [Abstract][Full Text] [Related]
5. Not all imatinib resistance in CML are BCR-ABL kinase domain mutations. Wei Y; Hardling M; Olsson B; Hezaveh R; Ricksten A; Stockelberg D; Wadenvik H Ann Hematol; 2006 Dec; 85(12):841-7. PubMed ID: 17006667 [TBL] [Abstract][Full Text] [Related]
6. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973 [TBL] [Abstract][Full Text] [Related]
7. [Analysis of ABL tyrosine kinase point mutations in imatinib treated chronic myelogenous leukemia patients]. Qin YZ; Liu YR; Li JL; Ruan GR; Zhu HH; Jiang Q; Fu JY; Lu Y; Chang Y; Li LD; Huang XJ; Chen SS; Qiu JY Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3186-9. PubMed ID: 16405837 [TBL] [Abstract][Full Text] [Related]
8. Cytogenetic and molecular mechanisms of resistance to imatinib. Hochhaus A Semin Hematol; 2003 Apr; 40(2 Suppl 2):69-79. PubMed ID: 12783379 [TBL] [Abstract][Full Text] [Related]
9. [Bcr-Abl inhibition as molecular therapy approach in chronic myeloid leukemia]. Buchdunger E Med Klin (Munich); 2002 Jan; 97 Suppl 1():2-6. PubMed ID: 11831067 [TBL] [Abstract][Full Text] [Related]
10. Preexistence and evolution of imatinib mesylate-resistant clones in chronic myelogenous leukemia detected by a PNA-based PCR clamping technique. Kreuzer KA; Le Coutre P; Landt O; Na IK; Schwarz M; Schultheis K; Hochhaus A; Dörken B Ann Hematol; 2003 May; 82(5):284-9. PubMed ID: 12692682 [TBL] [Abstract][Full Text] [Related]
11. Dynamics of BCR-ABL mutated clones prior to hematologic or cytogenetic resistance to imatinib. Ernst T; Erben P; Müller MC; Paschka P; Schenk T; Hoffmann J; Kreil S; La Rosée P; Hehlmann R; Hochhaus A Haematologica; 2008 Feb; 93(2):186-92. PubMed ID: 18223278 [TBL] [Abstract][Full Text] [Related]
12. Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up. Lahaye T; Riehm B; Berger U; Paschka P; Müller MC; Kreil S; Merx K; Schwindel U; Schoch C; Hehlmann R; Hochhaus A Cancer; 2005 Apr; 103(8):1659-69. PubMed ID: 15747376 [TBL] [Abstract][Full Text] [Related]
13. Mutation in the ATP-binding pocket of the ABL kinase domain in an STI571-resistant BCR/ABL-positive cell line. Ricci C; Scappini B; Divoky V; Gatto S; Onida F; Verstovsek S; Kantarjian HM; Beran M Cancer Res; 2002 Nov; 62(21):5995-8. PubMed ID: 12414617 [TBL] [Abstract][Full Text] [Related]
14. Hematological and molecular response evaluation of CML patients on imatinib. Gupta A; Prasad K J Assoc Physicians India; 2007 Feb; 55():109-13. PubMed ID: 17571739 [TBL] [Abstract][Full Text] [Related]
15. ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia. Soverini S; Martinelli G; Rosti G; Bassi S; Amabile M; Poerio A; Giannini B; Trabacchi E; Castagnetti F; Testoni N; Luatti S; de Vivo A; Cilloni D; Izzo B; Fava M; Abruzzese E; Alberti D; Pane F; Saglio G; Baccarani M J Clin Oncol; 2005 Jun; 23(18):4100-9. PubMed ID: 15867198 [TBL] [Abstract][Full Text] [Related]
16. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia]. Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031 [TBL] [Abstract][Full Text] [Related]
17. New tyrosine kinase inhibitors in chronic myeloid leukemia. Martinelli G; Soverini S; Rosti G; Cilloni D; Baccarani M Haematologica; 2005 Apr; 90(4):534-41. PubMed ID: 15820950 [TBL] [Abstract][Full Text] [Related]
18. BCR-ABL1 mutations in patients with imatinib-resistant Philadelphia chromosome-positive leukemia by use of the PCR-Invader assay. Ono T; Miyawaki S; Kimura F; Kanamori H; Ohtake S; Kitamura K; Fujita H; Sugiura I; Usuki K; Emi N; Tamaki S; Aoyama Y; Kaya H; Naoe T; Tadokoro K; Yamaguchi T; Ohno R; Ohnishi K; Leuk Res; 2011 May; 35(5):598-603. PubMed ID: 21239056 [TBL] [Abstract][Full Text] [Related]
19. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Gorre ME; Mohammed M; Ellwood K; Hsu N; Paquette R; Rao PN; Sawyers CL Science; 2001 Aug; 293(5531):876-80. PubMed ID: 11423618 [TBL] [Abstract][Full Text] [Related]
20. Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment. Roche-Lestienne C; Soenen-Cornu V; Grardel-Duflos N; Laï JL; Philippe N; Facon T; Fenaux P; Preudhomme C Blood; 2002 Aug; 100(3):1014-8. PubMed ID: 12130516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]